AU5836700A - Peptides for therapeutic use - Google Patents
Peptides for therapeutic useInfo
- Publication number
- AU5836700A AU5836700A AU58367/00A AU5836700A AU5836700A AU 5836700 A AU5836700 A AU 5836700A AU 58367/00 A AU58367/00 A AU 58367/00A AU 5836700 A AU5836700 A AU 5836700A AU 5836700 A AU5836700 A AU 5836700A
- Authority
- AU
- Australia
- Prior art keywords
- peptides
- therapeutic use
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4721—Lipocortins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13722799P | 1999-06-01 | 1999-06-01 | |
US60137227 | 1999-06-01 | ||
IE20000170 | 2000-03-03 | ||
IE2000/0170 | 2000-03-03 | ||
IE2000/0303 | 2000-04-13 | ||
IE20000303A IE20000303A1 (en) | 2000-04-13 | 2000-04-13 | Peptides for Therapeutic use |
IE2000/0386 | 2000-05-18 | ||
IE20000385 | 2000-05-18 | ||
IE2000/0385 | 2000-05-18 | ||
IE20000386 | 2000-05-18 | ||
PCT/IB2000/000895 WO2000072868A2 (en) | 1999-06-01 | 2000-06-01 | Peptides for therapeutic use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5836700A true AU5836700A (en) | 2000-12-18 |
Family
ID=27517569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU58367/00A Abandoned AU5836700A (en) | 1999-06-01 | 2000-06-01 | Peptides for therapeutic use |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5836700A (en) |
WO (1) | WO2000072868A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060281681A1 (en) | 1997-05-28 | 2006-12-14 | Pilon Aprile L | Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease |
GB0014870D0 (en) | 2000-06-16 | 2000-08-09 | King S College London | Peptides |
AU2008303941A1 (en) * | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Use of the peptide Pro-Gly-Thr-Cys-Glu-Ile-Cys-Ala-Tyr-Ala-Ala-Cys-Thr-Gly-Cys as a therapeutic agent |
JP2010539045A (en) * | 2007-09-11 | 2010-12-16 | モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト | Use of fibronectin fragment (196-203) as therapeutic agent |
EP2303308A4 (en) | 2008-05-13 | 2012-11-07 | Clarassance Inc | Recombinant human cc10 and compositions thereof for use in the treatment of nasal rhinitis |
US9168285B2 (en) | 2009-10-15 | 2015-10-27 | Therabron Therapeutics, Inc. | Recombinant human CC10 protein for treatment of influenza and ebola |
NZ599511A (en) * | 2009-10-15 | 2014-06-27 | Clarassance Inc | Recombinant human cc10 protein for treatment of influenza |
US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5266562A (en) * | 1987-11-19 | 1993-11-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Anti-inflammatory agents |
BE1006919A3 (en) * | 1993-03-15 | 1995-01-24 | Ley Marc Jozef Philemon De | PHARMACEUTICAL COMPOSITION BASED ON CLARA cell protein CC10, AND THEIR USE AS MEDICINE AND diagnostic. |
US20020160948A1 (en) * | 1998-07-21 | 2002-10-31 | Aprile Pilon | Recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
DE60036697D1 (en) * | 1999-04-21 | 2007-11-22 | Us Gov Health & Human Serv | UTEROGLOBIN FOR THE TREATMENT OF IGA-MEDIATED AUTOIMMUNE DISEASES |
-
2000
- 2000-06-01 AU AU58367/00A patent/AU5836700A/en not_active Abandoned
- 2000-06-01 WO PCT/IB2000/000895 patent/WO2000072868A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2000072868A3 (en) | 2001-12-06 |
WO2000072868A2 (en) | 2000-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1200316A1 (en) | Therapeutic microfoams | |
AU5259100A (en) | Medicament | |
AU7358700A (en) | Dolastatin peptides | |
AU6894600A (en) | Therapeutic polypeptides and methods for using same | |
GB0128994D0 (en) | Peptides | |
AU2001259837A1 (en) | Therapeutic pore-forming peptides | |
AU1608201A (en) | Human zven proteins | |
AU2451500A (en) | Therapeutic agents | |
AU5836700A (en) | Peptides for therapeutic use | |
AU3978700A (en) | Medical use | |
EP1147130A4 (en) | Alpha-conotoxin peptides | |
AU5973600A (en) | Therapeutic agents | |
EP1159288A4 (en) | Alpha-conotoxin peptides | |
AU1043601A (en) | Medical use | |
AU4456800A (en) | Human hac3 | |
AU3774000A (en) | Conformationally constrained peptides | |
GB9903408D0 (en) | Peptides | |
AU6150200A (en) | Therapeutic agents | |
AUPQ386899A0 (en) | Peptide compounds | |
AU5817400A (en) | Therapeutic agents | |
AU3808800A (en) | Compounds for use in therapy | |
AU7655700A (en) | Medicament combinations | |
AU7420800A (en) | Medical use | |
GB9911238D0 (en) | Therapeutic use | |
AU5449200A (en) | Cytoskeleton-associated proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |